Literature DB >> 7555188

Antithrombotic therapy in atrial fibrillation.

A Laupacis, G Albers, J Dalen, M Dunn, W Feinberg, A Jacobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7555188     DOI： 10.1378/chest.108.4_supplement.352s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  31 in total

Review 1.  In-hospital approach to newly recognized atrial fibrillation.

Authors:  C D Kimmelstiel; M Homoud; C A Clyne; M Estes III
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.

Authors:  S J Connolly
Journal:  BMJ       Date:  2000-05-06

Review 3.  Cardioversion in atrial fibrillation: indications, thromboembolic prophylaxis, and role of transesophageal echocardiography.

Authors:  M L Main; A L Klein
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

4.  Atrial Fibrillation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

Review 5.  Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation.

Authors:  R H Foster; M I Wilde; A Markham
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 6.  Pharmacogenetics of warfarin: challenges and opportunities.

Authors:  Ming Ta Michael Lee; Teri E Klein
Journal:  J Hum Genet       Date:  2013-05-09       Impact factor: 3.172

7.  Preventive therapies: weighing the pros and cons.

Authors:  A Laupacis
Journal:  CMAJ       Date:  1996-05-15       Impact factor: 8.262

8.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

Review 9.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

10.  Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.

Authors:  A Laupacis; K Sullivan
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.